Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 55289-959 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

55289959 Label - 55289959

55289959 Label - 55289959

Figure1

Figure1

Figure2

Figure2

This appears to be a chart or table displaying mean pain scores for a study with different dosing periods and treatment options, including a placebo, gabapentin at 1800 mg/day, and gabapentin at 2400 mg/day. The chart includes a baseline measurement and a 4-week and 8-week fixed dose period.*

Figure3

Figure3

The given description comprises the result table of two controlled clinical studies on PHN (Postherpetic Neuralgia) treatments, along with the proportion of responders, which are patients that achieved a 50% reduction in pain score at Endpoint. The table shows various percentages for PHN treatments, and the asterisk symbols indicate the level of significance.*

Figure4

Figure4

Structure.jpg - Structure

Structure.jpg - Structure

Equation.jpg - equation

Equation.jpg - equation

This is a calculation for estimating the glomerular filtration rate (GFR) based on age, weight, and serum creatinine levels of a patient. The first formula uses age in years and weight in kilograms, while the second formula uses serum creatinine levels in milligrams per deciliter. The second formula also includes an adjustment factor of 0.85 for female patients. This information may be used in assessing the renal function of a patient.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.